Showing results (1341-1350 of 2,897) with videos related to
Sort By:
Pageof 290
Molecular Diversity|September 26, 2024
Design, synthesis, and nematicidal activity of novel 1,2,4-oxadiazole derivatives containing amide fragmentsYuqin Ou, Xue Guo, Qi Zhang, et al.Molecular Diversity|August 3, 2024
MolGC: molecular geometry comparator algorithm for bond length mean absolute error computation on moleculesJavier Camarillo-Cisneros, Graciela Ramirez-Alonso, Carlos Arzate-Quintana, et al.Molecular Diversity|July 26, 2024
From antibiotic to antiviral: computational screening reveals a multi-targeting antibiotic from Streptomyces spp. against Nipah virus fusion proteinsNyzar Mabeth O Odchimar, Mark Andrian B Macalalad, Fredmoore L OroscoMolecular Diversity|May 14, 2025
Discovery and optimization of novel indolecarboxylic acid derivative as potent glucagon-like peptide‑1 receptor agonistsWanting Zhao, Yuqian Yin, Zhuo Shi, et al.Molecular Diversity|May 13, 2025
Enhancing PI3Kγ inhibitor discovery: a machine learning-based virtual screening approach integrating pharmacophores, docking, and molecular descriptorsLei Jia, Lei Xu, Yanfei Cai, et al.Molecular Diversity|May 22, 2025
Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: design, synthesis and anti-inflammatory activityWael A A Fadaly, Ahmed Elshewy, Ahmed H A Abusabaa, et al.Molecular Diversity|May 20, 2025
Machine learning approaches for predicting the small molecule-miRNA associations: a comprehensive reviewAshish Panghalia, Vikram SinghMolecular Diversity|April 29, 2025
GLP-1R agonists: recent advances, current gaps, and future challengesAnukriti Saran, Riya Raisinghani, Sarvesh Paliwal, et al.Molecular Diversity|April 27, 2025
Co-development of efflux pump inhibitors with antibiotics on targeting structural and mutational aspects of AcrB subunitShweta Singh Chauhan, Tanya Jamal, Anshika Gupta, et al.Molecular Diversity|April 28, 2025
Computational approach for the evaluation of sesquiterpene lactone as a modulator of cannabinoid receptor type 2 for neurodegenerative disease prophylacticsRam Lal Swagat Shrestha, Ashika Tamang, Sujan Dhital, et al.Pageof 290